We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
eGain
EGAN
$201M
| $348K | ﹤0.01% |
31,333
+6,025
| +24% | +$54.8K |
|
|
ZEUS
2502
DELISTED
Olympic Steel
ZEUS
| $347K | ﹤0.01% |
29,541
-11,689
| -28% | -$116K |
|
|
CBPO
2503
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $347K | ﹤0.01% |
+3,400
| New | +$364K |
|
2504
Allient
ALNT
$1.92B
| $346K | ﹤0.01% |
14,723
+908
| +7% | +$18.9K |
|
2505
Blue Bird Corp
BLBD
$2.18B
| $345K | ﹤0.01% |
23,033
+1,925
| +9% | +$24.1K |
|
2506
NN Inc
NNBR
$311M
| $345K | ﹤0.01% |
72,870
+19
| +0% | +$66 |
|
|
RAPT
2507
DELISTED
RAPT Therapeutics
RAPT
| $345K | ﹤0.01% |
+1,486
| New | +$230K |
|
|
BELFB
2508
Bel Fuse Inc Class B
BELFB
$4.21B
| $344K | ﹤0.01% |
32,095
-4,620
| -13% | -$42.2K |
|
|
PCSB
2509
DELISTED
PCSB Financial Corporation
PCSB
| $343K | ﹤0.01% |
27,030
-5,125
| -16% | -$66.8K |
|
|
EMWP
2510
DELISTED
Eros Media World PLC
EMWP
| $343K | ﹤0.01% |
5,425
+627
| +13% | +$35.4K |
|
2511
OneSpaWorld
OSW
$2.66B
| $342K | ﹤0.01% |
71,758
-455
| -0.6% | -$2.47K |
|
|
TCRR
2512
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $342K | ﹤0.01% |
22,260
+9,922
| +80% | +$114K |
|
2513
Oric Pharmaceuticals
ORIC
$1.4B
| $341K | ﹤0.01% |
+10,109
| New | +$323K |
|
|
CPLG
2514
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $341K | ﹤0.01% |
80,886
-7,935
| -9% | -$31K |
|
2515
Ceco Environmental
CECO
$4.14B
| $340K | ﹤0.01% |
51,603
-1,215
| -2% | -$6.58K |
|
2516
Bristow Group
VTOL
$1.36B
| $338K | ﹤0.01% |
24,245
-18,053
| -43% | -$193K |
|
|
HUD
2517
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $337K | ﹤0.01% |
69,158
-1,435
| -2% | -$7.49K |
|
2518
Chord Energy
CHRD
$7.39B
| $336K | ﹤0.01% |
448,241
-700,562
| -61% | -$453K |
|
2519
Arcutis Biotherapeutics
ARQT
$3.18B
| $334K | ﹤0.01% |
11,031
+1,150
| +12% | +$33.2K |
|
2520
Franklin Covey
FC
$246M
| $334K | ﹤0.01% |
15,620
+2,700
| +21% | +$54.7K |
|
2521
Southern First Bancshares
SFST
$600M
| $334K | ﹤0.01% |
12,041
+955
| +9% | +$25.9K |
|
2522
ASML
ASML
$669B
| $333K | ﹤0.01% |
+905
| New | +$284K |
|
|
HMHC
2523
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $333K | ﹤0.01% |
183,791
-1,118
| -0.6% | -$1.79K |
|
2524
Cadiz
CDZI
$291M
| $332K | ﹤0.01% |
32,666
+5,800
| +22% | +$64.8K |
|
|
EXPR
2525
DELISTED
Express, Inc.
EXPR
| $332K | ﹤0.01% |
10,777
-1,730
| -14% | -$63.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.